US Stock MarketDetailed Quotes

SPRO Spero Therapeutics

Watchlist
  • 1.395
  • -0.005-0.36%
Close Jul 22 16:00 ET
75.31MMarket Cap3.17P/E (TTM)

Spero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spero Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 15, 2024

Revenue(YoY)

9.27M

+347.90%
EPS(YoY)

-0.24

+4.00%
Analyst Rating

Buy

Mar 13, 2024

Spero Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 11.467M--
--2024/Q2-- / 3.267M--
May 15, 20242024/Q19.267M / 21.533M--
Mar 13, 20242023/Q473.524M / 18.633M--
Nov 13, 20232023/Q325.473M / 14.967M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 11.467M--
--2024/Q2-- / 3.267M--
May 15, 20242024/Q19.267M / 21.533M--
Mar 13, 20242023/Q473.524M / 18.633M--
Nov 13, 20232023/Q325.473M / 14.967M--

Unlock Free Earnings Estimates

Spero Therapeutics Earnings Reports

  • Spero Therapeutics | 10-Q: Quarterly report

    May 15 16:07 ET

  • Spero Therapeutics | 10-K: Annual report

    Mar 13 16:15 ET

  • Spero Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 16:02 ET

  • Spero Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 13, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg